Previous research has demonstrated that VT-1161 was found to exhibit favorable antifungal activity against systemic Candida infections, with high potency against the candidal CYP51 target enzyme and minimal interaction with human CYP51 [27]. This evidence concerns the gene CYP51A1 and candidiasis.